Population
Patients with essential hypertension
Design
Review
Authors
Loading...
Suggests distinct NO pathway targets in hypertensive endothelial dysfunction; leaves open clinical translation pending prospective validation.
This review highlights that the defect in the NO system causing endothelial dysfunction in hypertension is distinct from that in hypercholesterolemia, pointing toward novel therapeutic targets.
Julio A. Panza (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: